Trial · NCT07045155
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 22 of 22
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Other | Hyperkalemia: The incidence of hyperkalemia will be observed in the three groups. | up to 24 weeks | Safety endpoints |
| Other | Major adverse cardiovascular events (MACE): The types, severity, and incidence of MACE will be reported. MACE includes death, non-fatal myocardial infarction, and stroke. | up to 24 weeks | Safety endpoints |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07045155/registered?page=2